Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Almirall SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Almirall SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Almirall SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Almirall SA, Medical Devices Deals, 2012 to YTD 2018 12
Almirall SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Almirall SA, Pharmaceuticals & Healthcare, Deal Details 15
Asset Purchase 15
Almirall Acquires Dermatology Portfolio from Allergan 15
Almirall Acquires Rights to Veltin and Altabax from Stiefel 16
Aqua Pharma Acquires US Rights To Verdeso Foam From Stiefel 17
Partnerships 18
Evotec and Almirall Enter into Research Agreement 18
Almirall Enters into Research Agreement with Mercachem 19
Nuevolution Enters into Co-Development Agreement with Almirall 20
Medigene Enters Into Co-Marketing Agreement With Taurus Pharma For Veregen 21
Almirall Enters Into Commercialization Agreement With Quintiles 22
Bayer HealthCare And Almirall Enter Into Co-Promotion Agreement For Rivaroxaban In Spain 23
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus 24
Licensing Agreements 25
Almirall Enters into Licensing Agreement with AstraZeneca 25
Almirall Signs Licensing Agreement with Athenex for KX2-391 26
Luqa Pharma Enters into Licensing Agreement with Polichem 27
Almirall Enters into Licensing Agreement with Patagonia Pharma 28
Almirall Enters into Licensing Agreement with Bicosome 29
Allergan Enters into Licensing Agreement with Almirall for Constella 30
Aslan Pharma Expands Licensing Agreement with Almirall for LAS186323 31
Almirall Enters into Licensing Agreement with Sun Pharma for Tildrakizumab 32
Laboratorios Rubio Enters Into Licensing Agreement With Polichem 33
Almirall Enters Into Licensing Agreement With Forest Labs For Aclidinium bromide 34
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 35
Almirall Enters Into Licensing Agreement With Forest Labs For Linaclotide 37
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 38
Almirall Enters Into Licensing Agreement With Daewoong Pharma For Aclidinium 39
Equity Offering 40
Suneva Medical Raises USD15 Million in Series C Equity Investment 40
Debt Offering 41
Almirall Raises USD447.4 Million in Private Placement of 4.625% Notes Due 2021 41
Asset Transactions 42
Cipher Pharma Acquires Canadian Rights to Vaniqa and Actikerall from Almirall 42
Astrazeneca Acquires Almirall Respiratory Franchise for up to USD2.1 billion 43
Acquisition 45
Grunenthal Group to Acquire Almirall de Mexico for USD33.4 Million 45
Almirall Acquires Poli 46
Actavis May Acquire Almirall 47
Almirall Completes Acquisition Of Aqua Pharma From RoundTable Healthcare Partners For US$403 Million 48
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 50
Almirall SA – Key Competitors 51
Almirall SA – Key Employees 52
Almirall SA – Locations And Subsidiaries 53
Head Office 53
Other Locations & Subsidiaries 53
Recent Developments 55
Strategy And Business Planning 55
Aug 06, 2018: Allergan divests five dermatology medicines to Almirall for $550m 55
Sep 13, 2017: Almirall Renews its Corporate Identity, Aligned with its Focus on Skin Health 56
Financial Announcements 57
May 14, 2018: Almirall Announces Financial Results Q1 2018 57
Feb 23, 2018: Almirall’s Full-Year 2017 Results 59
Nov 06, 2017: Almirall’s Q3 results 2017 61
Jul 24, 2017: Almirall’s H1 Results 2017: Reiterating Recent Guidance 63
May 08, 2017: Almirall’s Q1 results 2017, driven by Dermatology in Europe 64
Feb 27, 2017: Almirall Full-Year 2016 results: Strong Dermatology results and promising pipeline 66
Corporate Communications 68
Aug 22, 2017: Almirall announces Ron Menezes as new President & General Manager at Aqua Pharmaceuticals 68
Appendix 69
Methodology 69
About GlobalData 69
Contact Us 69
Disclaimer 69
Almirall SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Almirall SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 8
Almirall SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Almirall SA, Deals By Therapy Area, 2012 to YTD 2018 10
Almirall SA, Medical Devices Deals, 2012 to YTD 2018 12
Almirall SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 13
Almirall Acquires Dermatology Portfolio from Allergan 15
Almirall Acquires Rights to Veltin and Altabax from Stiefel 16
Aqua Pharma Acquires US Rights To Verdeso Foam From Stiefel 17
Evotec and Almirall Enter into Research Agreement 18
Almirall Enters into Research Agreement with Mercachem 19
Nuevolution Enters into Co-Development Agreement with Almirall 20
Medigene Enters Into Co-Marketing Agreement With Taurus Pharma For Veregen 21
Almirall Enters Into Commercialization Agreement With Quintiles 22
Bayer HealthCare And Almirall Enter Into Co-Promotion Agreement For Rivaroxaban In Spain 23
Almirall Enters Into Integrated Drug Discovery Collaboration With BioFocus 24
Almirall Enters into Licensing Agreement with AstraZeneca 25
Almirall Signs Licensing Agreement with Athenex for KX2-391 26
Luqa Pharma Enters into Licensing Agreement with Polichem 27
Almirall Enters into Licensing Agreement with Patagonia Pharma 28
Almirall Enters into Licensing Agreement with Bicosome 29
Allergan Enters into Licensing Agreement with Almirall for Constella 30
Aslan Pharma Expands Licensing Agreement with Almirall for LAS186323 31
Almirall Enters into Licensing Agreement with Sun Pharma for Tildrakizumab 32
Laboratorios Rubio Enters Into Licensing Agreement With Polichem 33
Almirall Enters Into Licensing Agreement With Forest Labs For Aclidinium bromide 34
Almirall Enters Into Licensing Agreement With Invida For Aclidinium 35
Almirall Enters Into Licensing Agreement With Forest Labs For Linaclotide 37
Almirall Enters Into Licensing Agreement With Menarini Biotech For Aclidinium Bromide 38
Almirall Enters Into Licensing Agreement With Daewoong Pharma For Aclidinium 39
Suneva Medical Raises USD15 Million in Series C Equity Investment 40
Almirall Raises USD447.4 Million in Private Placement of 4.625% Notes Due 2021 41
Cipher Pharma Acquires Canadian Rights to Vaniqa and Actikerall from Almirall 42
Astrazeneca Acquires Almirall Respiratory Franchise for up to USD2.1 billion 43
Grunenthal Group to Acquire Almirall de Mexico for USD33.4 Million 45
Almirall Acquires Poli 46
Actavis May Acquire Almirall 47
Almirall Completes Acquisition Of Aqua Pharma From RoundTable Healthcare Partners For US$403 Million 48
Almirall Acquires Stake In AB-Biotics, Biotechnology Company, For US$1.3 Million 50
Almirall SA, Key Competitors 51
Almirall SA, Key Employees 52
Almirall SA, Subsidiaries 53
List of Figures
Almirall SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Almirall SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Almirall SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Almirall SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 7
Almirall SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 8
Almirall SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 9
Almirall SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 10
Almirall SA, Medical Devices Deals, 2012 to YTD 2018 12